Aurelium BioPharma Inc. and a brighter future for early detection of cancer through innovative diagnostic tools.

Armed with scientific excellence, strategic partnerships and innovative diagnostics for early and reliable detection of breast, ovarian and drug-resistant cancers, Aurelium is at the forefront of providing answers, hope and a healthier future for all.

 more

   

US Patent issued to Aurelium...
 more
 
Aurelium signs agreement with Agilent...
 more
 
 
 
 
FFPE Extraction Kit
The EpitexTM FFPE protein extraction kit was optimized for extracting...
More
Breast Cancer Test
Brest cancer affects more than 217,000 women in the...
More
Ovarian Cancer Test
More than 20,180 women in the USA are diagnosed...
More
Chemo-Resistance
The development of clinical resistance to anti-cancer drugs...
More
 
Design by GENERATION CLIK